Diagnostic Imaging Devices are used for the visualization of structural and functional patterns of organs or tissues. Bone Densitometers are devices used to measure bone mineral density with techniques such as Dual-Energy X-ray Absorptiometry (DEXA), Quantitative Computed Tomography (QCT), Radiographic Absorptiometry (RA) and Quantitative Ultrasound (QUS). GlobalData uses proprietary data and analytics to provide a comprehensive report on the bone densitometers devices market, including market shares of different players within Portugal. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the bone densitometers market in Portugal was Hologic followed by GE HealthCare Technologies, Swissray Medical and Diagnostic Medical Systems.
DEXA and QUS are tracked under this category. DEXA has two different X-ray beams to estimate bone density in spine and hip.QUS measures the bone density using high frequency sound waves.
The value of the bone densitometers devices market within Portugal was expected to be over $1m in 2023.
For the latest complete market share analysis of bone densitometers device market in Portugal, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
